|
Volumn 56, Issue 4, 2001, Pages 314-316
|
Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis
|
Author keywords
Bisphosphonates; Bone mineral density; Cystic fibrosis; Osteoporosis; Pamidronate
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
CALCICHEW FORTE;
CALCIUM;
PAMIDRONIC ACID;
UNCLASSIFIED DRUG;
VITAMIN D;
ADULT;
ARTICLE;
BONE DENSITY;
BONE MINERAL;
BONE PAIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DRUG INDUCED DISEASE;
FEMUR;
FOREARM;
HUMAN;
INCIDENCE;
LUMBAR SPINE;
MAJOR CLINICAL STUDY;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANTI-INFLAMMATORY AGENTS;
BONE DENSITY;
BONE DISEASES, METABOLIC;
CALCIUM;
CYSTIC FIBROSIS;
DIPHOSPHONATES;
HUMANS;
INFUSIONS, INTRAVENOUS;
LONGITUDINAL STUDIES;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 0035063064
PISSN: 00406376
EISSN: None
Source Type: Journal
DOI: 10.1136/thorax.56.4.314 Document Type: Article |
Times cited : (65)
|
References (10)
|